Vitaspring Biomedical Co., Ltd. filed an 8-K on September 7, 2026, reporting significant changes to its executive leadership and board structure. Dr. Ssu-Chuan Lai resigned from all her positions with the company, including Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary, effective at 11:58 p.m. Pacific Time on September 7, 2026. The resignation was not the result of any disagreement with the Company regarding its operations, policies, or practices.
Immediately following the resignation, the Company appointed Jing-Zhou Chen as Chief Executive Officer, President, Chief Financial Officer, and Secretary, effective at 11:57 p.m. Pacific Time on September 7, 2026. Mr. Chen, age 40, is the founder and CEO of Dream Born Co., Ltd., a Taiwan-based mobile short-form video and consumer content application company. His prior experience includes roles as CEO and Managing Director at GBT Cloud Kitchen and Hongxi Enterprise Management, co-founding and heading operations at POKE25, and serving as Vice President of Operations at G-Store Smart Retail Technology. Mr. Chen holds a B.S. in Electrical Engineering from National United University and is currently an Executive MBA student at National Taipei University of Technology.
In a separate action, the Company elected Shao-Hsiang Shih as a Director and Chairman of the Board, effective at 11:56 p.m. Pacific Time on September 7, 2026. Mr. Shih, age 54, has served as Director of Administrative Management at Century Publishing Co. in Taiwan since 2020. The Company noted that Mr. Shih’s extensive management and administrative experience, along with his educational background, would be beneficial to the Company.
The Company has not entered into an employment agreement with Mr. Chen, and no compensation is currently payable to him for his service as an officer. Similarly, no compensation is currently payable to Mr. Shih for his service as a director or Chairman, unless otherwise determined by the Board. The Company has not entered into an indemnification agreement with either new appointee as of the date of the report.
